Business Wire

OncoNano Medicine Announces Positive Phase 2 Data for Pegsitacianine as an adjunct to Cytoreductive Surgery of Peritoneal Carcinomatosis

SOUTHLAKE, Texas--(BUSINESS WIRE)--OncoNano Medicine, Inc. today announced positive interim clinical results from an ongoing Phase 2 study of its lead clinical development candidate, pegsitacianine, ...
ascopubs.org

Systemic chemotherapy (SC) before cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal mucinous carcinomatosis of ...

Survival analysis of various treatment options in mucinous adenocarcinoma of the ano-rectal region: A SEER database analysis. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This ...
Healthline

What Is Cytoreductive Surgery?

Cytoreductive surgery removes tumors that have spread throughout your abdominal cavity. It’s often combined with another procedure called hyperthermic intraperitoneal chemotherapy. You may need ...
ascopubs.org

Survival analysis of various treatment options in mucinous adenocarcinoma of the ano-rectal region: A SEER database analysis.

Comparison of clinical characteristics and prognosis for hepatocellular carcinoma in Uyghur patients in Xinjiang of China. Systemic chemotherapy (SC) before cytoreductive surgery (CRS) and ...
Fred Hutch

Hyperthermic intraperitoneal chemotherapy offers important option for patients with peritoneal cancer

Hyperthermic intraperitoneal chemotherapy (HIPEC) provides an important treatment option that can improve survival for some patients with advanced peritoneal cancer. Managing this disease — and ...